Bone Marrow Transplantation - Table of Contents alert Volume 47 Issue 8

TABLE OF CONTENTS Volume 47, Issue 8 (August 2012) In this issue Reviews Special Report Original Articles Letters to the Editor Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement With an Impact Factor of 3.746* and ranked sixth in Transplantation, Bone Marrow Transplantation is one of the most highly-regarded journals in the field. Bone Marrow Transplantation provides: - High quality research - Hassle-free submission - High visibility via nature.com - Open access option Submit your next paper to Bone Marrow Transplantation www.nature.com/bmt/for_authors.html *2011 Journal Citation Report® (Thomson Reuters, 2012) Advertisement Take part in our reader survey for a chance to win a MacBook Air As a reader of NPG's clinical, academic and society-owned journals, we invite you to take part in a survey on your use of our journals and their associated websites. Take the survey and be entered into a prize draw for a MacBook Air* *Terms & conditions apply   Reviews Top Is adoptive T-cell therapy for solid tumors coming of age? P Pedrazzoli, P Comoli, D Montagna, T Demirer and M Bregni on behalf of the EBMT STWP Bone Marrow Transplant 2012 47: 1013-1019; advance online publication, August 1, 2011; 10.1038/bmt.2011.155 Abstract | Full Text Bronchiolitis obliterans after allo-SCT: clinical criteria and treatment options H H Uhlving, F Buchvald, C J Heilmann, K G Nielsen, M Gormsen and K G Müller Bone Marrow Transplant 2012 47: 1020-1029; advance online publication, August 29, 2011; 10.1038/bmt.2011.161 Abstract | Full Text Special Report Top ECIL-3 classical diagnostic procedures for the diagnosis of invasive fungal diseases in patients with leukaemia M C Arendrup, J Bille, E Dannaoui, M Ruhnke, C-P Heussel and C Kibbler Bone Marrow Transplant 2012 47: 1030-1045; advance online publication, January 9, 2012; 10.1038/bmt.2011.246 Abstract | Full Text Original Articles Top STEM CELL PROCUREMENT European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European Consortium of stem cell mobilization K Hübel, M M Fresen, J F Apperley, G W Basak, K W Douglas, I H Gabriel, C Geraldes, O Jaksic, Z Koristek, N Kröger, F Lanza, R M Lemoli, G Mikala, D Selleslag, N Worel, M Mohty and R F Duarte Bone Marrow Transplant 2012 47: 1046-1050; advance online publication, November 14, 2011; 10.1038/bmt.2011.216 Abstract | Full Text Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration M E Horwitz, J P Chute, C Gasparetto, G D Long, C McDonald, A Morris, D A Rizzieri, K M Sullivan and N J Chao Bone Marrow Transplant 2012 47: 1051-1055; advance online publication, November 14, 2011; 10.1038/bmt.2011.217 Abstract | Full Text CORD BLOOD STEM CELLS Importance of day 21 BM chimerism in sustained neutrophil engraftment following double-unit cord blood transplantation S Avery, M H Voss, A M Gonzales, M Lubin, H Castro-Malaspina, S Giralt, N A Kernan, A Scaradavou, C V Hedvat, C E Stevens and J N Barker Bone Marrow Transplant 2012 47: 1056-1060; advance online publication, December 5, 2011; 10.1038/bmt.2011.236 Abstract | Full Text PEDIATRIC TRANSPLANTS HLA-matched sibling stem cell transplantation in children with β-thalassemia with anti-thymocyte globulin as part of the preparative regimen: the Greek experience E Goussetis, I Peristeri, V Kitra, G Vessalas, A Paisiou, M Theodosaki, E Petrakou, M N Dimopoulou and S Graphakos Bone Marrow Transplant 2012 47: 1061-1066; advance online publication, November 14, 2011; 10.1038/bmt.2011.219 Abstract | Full Text Osteonecrosis in children after allogeneic hematopoietic cell transplantation: study of prevalence, risk factors and longitudinal changes using MR imaging S Sharma, W-H Leung, P Deqing, J Yang, R Rochester, L Britton, M D Neel, K K Ness and S C Kaste Bone Marrow Transplant 2012 47: 1067-1074; advance online publication, December 12, 2011; 10.1038/bmt.2011.234 Abstract | Full Text ALLOGRAFTING Validation of pretransplantation assessment of mortality risk score in the outcome of hematopoietic SCT in non-Caucasians Y Mori, T Teshima, K Kamezaki, K Kato, K Takenaka, H Iwasaki, T Miyamoto, K Nagafuji, T Eto and K Akashi Bone Marrow Transplant 2012 47: 1075-1081; advance online publication, November 21, 2011; 10.1038/bmt.2011.229 Abstract | Full Text AUTOGRAFTING Potential prolongation of PFS in mantle cell lymphoma after R-HyperCVAD: auto-SCT consolidation or rituximab maintenance T Ahmadi, J McQuade, D Porter, N Frey, A W Loren, S C Goldstein, J Svoboda, E Stadtmauer, S J Schuster and S D Nasta Bone Marrow Transplant 2012 47: 1082-1086; advance online publication, November 14, 2011; 10.1038/bmt.2011.218 Abstract | Full Text An auto-SCT-based total therapy resulted in encouraging outcomes in adolescents and young adults with acute lymphoblastic leukemia: report from a single center of China J Huang, D-H Zou, Z-J Li, M-W Fu, Y Xu, Y-Z Zhao, J-Y Qi, S-Z Feng, B-C Liu, D Lin, Y-C Mi, M-Z Han, J-X Wang and L-G Qiu Bone Marrow Transplant 2012 47: 1087-1094; advance online publication, December 19, 2011; 10.1038/bmt.2011.220 Abstract | Full Text POST-TRANSPLANT EVENTS Clinical effectiveness of hyperbaric oxygen therapy for BK-virus-associated hemorrhagic cystitis after allogeneic bone marrow transplantation J Savva-Bordalo, C Pinho Vaz, M Sousa, R Branca, F Campilho, R Resende, I Baldaque, O Camacho and A Campos Bone Marrow Transplant 2012 47: 1095-1098; advance online publication, November 14, 2011; 10.1038/bmt.2011.228 Abstract | Full Text GRAFT-VERSUS-TUMOR EFFECTS Prevention of relapse using granulocyte CSF-primed PBPCs following HLA-mismatched/haploidentical, T-cell-replete hematopoietic SCT in patients with advanced-stage acute leukemia: a retrospective risk-factor analysis Y Wang, D-H Liu, L-P Xu, K-Y Liu, H Chen, X-H Zhang, Y-H Chen, W Han, F-R Wang, J-Z Wang, C-H Yan and X-J Huang Bone Marrow Transplant 2012 47: 1099-1104; advance online publication, November 7, 2011; 10.1038/bmt.2011.213 Abstract | Full Text GRAFT-VERSUS-HOST DISEASE Intensification of GVHD prophylaxis with low-dose ATG-F before allogeneic PBSC transplantation from HLA-identical siblings in adult patients with hematological malignancies: results from a retrospective analysis F Bonifazi, G Bandini, M Arpinati, G Tolomelli, M Stanzani, M R Motta, S Rizzi, V Giudice, E Dan, E Massari, P Tazzari, A Bontadini, P Pagliaro and M Baccarani Bone Marrow Transplant 2012 47: 1105-1111; advance online publication, November 21, 2011; 10.1038/bmt.2011.225 Abstract | Full Text Escalated lymphodepletion followed by donor lymphocyte infusion can induce a graft-versus-host response without overwhelming toxicity T Guillaume, B Gaugler, P Chevallier, J Delaunay, S Ayari, A Clavert, F Rialland, S Le Gouill, N Blin, T Gastinne, B Mahé, V Dubruille, P Moreau and M Mohty Bone Marrow Transplant 2012 47: 1112-1117; advance online publication, November 28, 2011; 10.1038/bmt.2011.231 Abstract | Full Text PRE-CLINICAL STUDIES Survival time of cardiac allografts prolonged by isogeneic BMT in mice Z Chen, H Jiang, R Chen, S Feng, J Jin, Y Bi, H Yang and J Chen Bone Marrow Transplant 2012 47: 1118-1125; advance online publication, November 7, 2011; 10.1038/bmt.2011.215 Abstract | Full Text Letters to the Editor Top Allo-SCT in a patient with CRMCC with aplastic anemia using a reduced intensity conditioning regimen D Asai, S Osone, T Imamura, H Sakaguchi, N Nishio, H Kuroda, S Kojima and H Hosoi Bone Marrow Transplant 2012 47: 1126-1127; advance online publication, November 14, 2011; 10.1038/bmt.2011.221 Full Text Tolerance to liver allograft after allogeneic hematopoietic cell transplantation for severe aplastic anemia from the same HLA-matched sibling donor H Sun, G Therapondos, J Lipton and V Gupta Bone Marrow Transplant 2012 47: 1128-1130; advance online publication, November 14, 2011; 10.1038/bmt.2011.222 Full Text Patient information in stem cell transplantation from the perspective of health care professionals: A survey from the Nurses Group of the European Group for Blood and Marrow Transplantation M Kirsch, P Crombez, S Calza, C Eeltink and E Johansson Bone Marrow Transplant 2012 47: 1131-1133; advance online publication, December 5, 2011; 10.1038/bmt.2011.223 Full Text Clofarabine and CY do not yield reliable engraftment of hematopoietic stem cells J Karch, J Zhu, W C Ehmann and D Claxton Bone Marrow Transplant 2012 47: 1134-1135; advance online publication, November 14, 2011; 10.1038/bmt.2011.224 Full Text Plerixafor in AL amyloidosis: improved graft composition and faster lymphocyte recovery after auto-SCT in patient with end-stage renal-disease D Dunn, P Vikas, M Jagasia and B N Savani Bone Marrow Transplant 2012 47: 1136-1137; advance online publication, November 14, 2011; 10.1038/bmt.2011.226 Full Text Successful treatment with plasma exchange for disseminated cidofovir-resistant adenovirus disease in a pediatric SCT recipient T Nishikawa, K Nakashima, R Fukano, J Okamura and J Inagaki Bone Marrow Transplant 2012 47: 1138-1139; advance online publication, November 14, 2011; 10.1038/bmt.2011.227 Full Text Significant interaction of tacrolimus with ritonavir during allogeneic hematopoietic SCT in an HIV-infected patient M Miceli, S Cronin, L Ayash, G Alangaden and P H Chandrasekar Bone Marrow Transplant 2012 47: 1140-1142; advance online publication, November 28, 2011; 10.1038/bmt.2011.230 Full Text Alteration of Dickkopf-1 and receptor activator of nuclear factor-κB ligand during PBSC mobilization in healthy donors by G-CSF M Tanaka, T Yujiri, Y Tanaka, N Mitani, A Tanimura and Y Tanizawa Bone Marrow Transplant 2012 47: 1143-1144; advance online publication, November 28, 2011; 10.1038/bmt.2011.233 Full Text Advertisement Immunology and Cell Biology is proud to present a Special Feature and web focus on the role of type I IFNs in regulating immune responses, which include the reasons for the presence of IFNs, type I IFNs interactions with target cells in the immune system, and the roles and mechanisms of IFNs in specific organs or diseases. Access the Web Focus today!   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.